Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.
3d
Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.
BOSTON - Allarity Therapeutics, Inc. (NASDAQ: ALLR), a micro-cap biopharmaceutical company valued at $4.79 million, has announced a new protocol for its ongoing clinical trial of stenoparib, a ...
Over and over again, Carmen Boyd and her classmates picked up the fluffy, polyester fiberfill and stuffed it into the tiny ...
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at ...
As Abbey Boyce underwent chemotherapy for stage three breast cancer, she wanted to stand in front of a mirror and still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback